It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Which Altcoins Have Strong Tech And Low Market Cap combines advanced tech with room to grow. This intro guides evaluation of core tech, roadmap, and market activity.
28,655 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Epic Fury is spreading beyond energy prices, hitting travel, remittances, and food imports in Asia. The resulting pol...
Tired of rewards that lock you into one brand? Credit cards with flexible rewards let you choose how to redeem points...
A newly married couple received a $4,000 invoice from their in-laws after wedding costs exceeded an agreed cap, renew...
When a Lincoln Educational director sold a sizable block of shares, investors took note. This article breaks down the...
When a high-profile invite story surfaces, it hides practical money tips for everyday people. Learn how to budget for...
A fast-tracked June US-IRAN deal rattles risk assets while BTC holds near $66,000 and ETH begins to show life. FTX cl...
Century 21 Americana is entering Montana for the first time, acquiring Billings' Hometown Brokers to form Century 21 ...
A leading Substack economist warns that ghost gdp could erase friction in the economy, accelerating a white-collar re...
As the AI memory crunch enters its second year, three ETFs map different angles of the supply squeeze—from DRAM to br...
As of June 2026, households pursue financial independence by targeting $7,500 a month in dividend income to replace a...
Trust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...